Charles Schwab’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-775
| Closed | -$27K | – | 3593 |
|
|
2021
Q4 | $27K | Hold |
775
| – | – | ﹤0.01% | 3561 |
|
|
2021
Q3 | $48K | Sell |
775
-5,706
| -88% | -$353K | ﹤0.01% | 3455 |
|
|
2021
Q2 | $506K | Sell |
6,481
-3,503
| -35% | -$273K | ﹤0.01% | 3164 |
|
|
2021
Q1 | $558K | Buy |
9,984
+1,129
| +13% | +$63.1K | ﹤0.01% | 3036 |
|
|
2020
Q4 | $542K | Sell |
8,855
-616
| -7% | -$37.7K | ﹤0.01% | 2961 |
|
|
2020
Q3 | $1.15M | Buy |
9,471
+2,983
| +46% | +$363K | ﹤0.01% | 2639 |
|
|
2020
Q2 | $767K | Buy |
6,488
+1,146
| +21% | +$135K | ﹤0.01% | 2701 |
|
|
2020
Q1 | $284K | Buy |
5,342
+70
| +1% | +$3.72K | ﹤0.01% | 2910 |
|
|
2019
Q4 | $287K | Sell |
5,272
-359
| -6% | -$19.5K | ﹤0.01% | 2983 |
|
|
2019
Q3 | $1.37M | Buy |
5,631
+649
| +13% | +$157K | ﹤0.01% | 2493 |
|
|
2019
Q2 | $1.14M | Buy |
+4,982
| New | +$1.14M | ﹤0.01% | 2534 |
|